Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September
06 sept. 2022 06h30 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results
15 août 2022 16h05 HE
|
Helius Medical Technologies, Inc.
-- Net proceeds from August 2022 financing and cash on hand expected to fund operations through 2023 ---- Company to host call at 4:30pm today -- NEWTOWN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) --...
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022
10 août 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering
05 août 2022 08h38 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™
12 juil. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., July 12, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting
06 juin 2022 07h05 HE
|
Helius Medical Technologies, Inc.
-- Study finds significant improvement in gait deficit in multiple sclerosis patients using translingual neurostimulation (“PoNS Therapy®”) combined with a therapeutic exercise program -- -- Poster...
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®
01 juin 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference
31 mai 2022 08h36 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
24 mai 2022 16h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 24, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program
17 mai 2022 07h30 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...